Aug 12, 2026 04:01PM
May 13, 2026 04:01PM
Apr 21, 2026 08:30AM
Apr 21, 2026 08:30AM
Mar 25, 2026 04:01PM
Dec 10, 2025 08:30AM
Dec 10, 2025 08:30AM Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology
Nov 12, 2025 04:01PM
Oct 24, 2025 08:30AM
Oct 24, 2025 08:30AM
Aug 12, 2025 04:01PM
Aug 7, 2025 08:30AM
Aug 7, 2025 08:30AM
Jul 14, 2025 08:31AM Journey Medical expands Emrosi payer coverage to 65% of commercial lives
Jul 14, 2025 08:30AM
Jun 24, 2025 08:31AM
Jun 24, 2025 08:30AM
Jun 20, 2025 08:32AM
Jun 20, 2025 08:30AM
Jun 9, 2025 08:30AM
May 15, 2025 04:05PM Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
May 14, 2025 04:01PM
Apr 1, 2025 04:01PM
Apr 1, 2025 04:01PM
Mar 26, 2025 04:01PM
Mar 24, 2025 08:30AM
Mar 5, 2025 04:01PM
Mar 5, 2025 04:01PM Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea
Mar 4, 2025 04:01PM
Jan 23, 2025 08:30AM
Nov 14, 2024 04:10PM
Nov 12, 2024 04:01PM
Nov 4, 2024 07:01AM
Nov 4, 2024 07:00AM
Oct 25, 2024 08:30AM Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference
Oct 17, 2024 04:18PM
Oct 17, 2024 04:15PM
Aug 13, 2024 04:05PM
Aug 12, 2024 04:01PM
Jul 11, 2024 04:06PM
Jul 11, 2024 04:05PM
May 13, 2024 04:01PM Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
May 1, 2024 04:02PM
May 1, 2024 04:01PM
Apr 25, 2024 08:30AM
Mar 21, 2024 04:01PM
Mar 18, 2024 08:31AM
Mar 18, 2024 08:30AM
Mar 11, 2024 08:31AM Journey Medical Corp (DERM) Announces Presentation of Data from Phase 1 Trial of DFD-29
Mar 11, 2024 08:30AM

1,186,423 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All